Revolution Medicines GAAP EPS of -$0.92 misses by $0.09, revenue of $3.82M beats by $2.26M

• Revolution Medicines press release (NASDAQ:RVMD): Q2 GAAP EPS of -$0.92 misses by $0.09.
• Revenue of $3.82M (-58.1% Y/Y) beats by $2.26M.